tradingkey.logo
tradingkey.logo
Search

Trevi Therapeutics Inc

TRVI
Add to Watchlist
17.535USD
+0.355+2.07%
Close 07-24 16:00ETQuotes delayed by 15 min
2.25BMarket Cap
LossP/E TTM

TRVI Financials

See Trevi Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Trevi Therapeutics Inc Earnings Date

Latest Release
May 5, 2026
EPS / Forecast
-0.09/-0.08
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.32
32.46%
Analyst Rating
BUY
2026/07/26
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-3.06%-0.09
46.95%-0.06
37.79%-0.08
22.81%-0.09
19.74%-0.09
-36.94%-0.11
-68.70%-0.13
-68.88%-0.12
-68.77%-0.11
7.83%-0.08
---0.08
---0.07
---0.06
---0.09
---0.44
----
----
----
----
----
Net Profit
-27.58%-13.19M
27.15%-8.32M
10.87%-11.80M
0.41%-12.30M
5.16%-10.34M
-45.95%-11.41M
-72.02%-13.24M
-72.88%-12.35M
-70.32%-10.90M
-42.07%-7.82M
6.87%-7.70M
11.26%-7.14M
12.66%-6.40M
35.39%-5.50M
-13.94%-8.27M
17.79%-8.05M
12.45%-7.33M
10.53%-8.52M
1.67%-7.25M
-32.64%-9.79M
Debt to assets ratio
----
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
-83.67%0.03%
-52.85%0.09%
-40.27%0.13%
-97.63%0.16%
-97.70%0.17%
--0.19%
--0.21%
--6.65%
--7.44%
--8.41%
----
----
----
----
----
Operating profit
-30.01%-14.91M
16.52%-10.22M
1.21%-13.92M
-3.26%-13.72M
3.66%-11.47M
-37.05%-12.24M
-55.74%-14.09M
-58.54%-13.29M
-57.42%-11.91M
-34.19%-8.93M
-7.61%-9.04M
-7.19%-8.38M
-7.66%-7.56M
19.53%-6.66M
-20.99%-8.40M
14.69%-7.82M
13.15%-7.03M
10.01%-8.27M
4.10%-6.95M
-23.66%-9.17M
Net Profit
-27.58%-13.19M
27.15%-8.32M
10.87%-11.80M
0.41%-12.30M
5.16%-10.34M
-45.95%-11.41M
-72.02%-13.24M
-72.88%-12.35M
-70.32%-10.90M
-42.07%-7.82M
6.87%-7.70M
11.26%-7.14M
12.66%-6.40M
35.39%-5.50M
-13.94%-8.27M
17.79%-8.05M
12.45%-7.33M
10.53%-8.52M
1.67%-7.25M
-32.64%-9.79M
Current assets
66.75%176.12M
75.14%191.66M
194.49%198.30M
187.30%207.23M
37.59%105.62M
24.99%109.43M
-28.33%67.34M
-27.30%72.13M
-32.78%76.77M
-28.60%87.55M
-26.21%93.95M
24.19%99.21M
282.72%114.20M
223.04%122.62M
314.62%127.32M
107.60%79.89M
-29.22%29.84M
-17.96%37.96M
-44.38%30.71M
-16.97%38.48M
Total current liabilities
3.63%7.12M
-7.23%9.75M
-0.90%9.04M
36.86%9.24M
30.14%6.87M
80.44%10.51M
76.36%9.12M
43.32%6.75M
-60.03%5.28M
-56.54%5.82M
-64.67%5.17M
-69.47%4.71M
2.60%13.20M
5.31%13.40M
47.69%14.64M
64.01%15.43M
141.05%12.87M
129.05%12.72M
62.43%9.91M
39.00%9.41M
Total assets
67.85%179.61M
74.43%193.44M
189.31%199.36M
182.26%208.34M
36.21%107.00M
24.05%110.90M
-28.14%68.91M
-26.90%73.81M
-32.40%78.56M
-27.32%89.40M
-25.29%95.90M
24.03%100.98M
282.43%116.20M
219.73%123.02M
306.26%128.36M
107.96%81.41M
-29.11%30.39M
-18.37%38.48M
-43.46%31.60M
-16.72%39.15M
Total liabilities
-0.90%7.48M
-9.43%10.20M
-3.73%9.57M
28.94%9.85M
21.24%7.55M
64.18%11.26M
58.11%9.94M
29.34%7.64M
-56.99%6.22M
-55.93%6.86M
-65.94%6.29M
-71.75%5.90M
-27.36%14.47M
-27.31%15.56M
-8.70%18.46M
-2.40%20.90M
3.88%19.92M
7.81%21.40M
-0.22%20.22M
207.13%21.41M
Total equity
73.07%172.13M
83.90%183.24M
221.84%189.79M
199.96%198.49M
37.50%99.46M
20.71%99.64M
-34.19%58.97M
-30.40%66.17M
-28.90%72.33M
-23.18%82.55M
-18.46%89.61M
57.11%95.07M
872.30%101.73M
529.34%107.46M
865.76%109.90M
241.20%60.52M
-55.82%10.46M
-37.41%17.07M
-68.05%11.38M
-55.70%17.74M
Net operating income
-23.83%-16.69M
20.09%-7.63M
-13.86%-10.88M
-16.33%-10.10M
-28.76%-13.48M
-50.18%-9.55M
-31.28%-9.56M
12.07%-8.68M
-27.69%-10.47M
-0.44%-6.36M
15.12%-7.28M
-59.89%-9.88M
-15.58%-8.20M
-1.64%-6.33M
-18.44%-8.58M
21.80%-6.18M
6.41%-7.09M
30.20%-6.23M
-3.93%-7.24M
6.38%-7.90M
Net investment
270.49%16.96M
-28.22%-30.61M
-764.38%-50.94M
-194.29%-2.61M
-22.99%-9.95M
-285.85%-23.87M
-57.36%7.67M
-85.91%2.77M
-190.28%-8.09M
126.59%12.85M
470.76%17.98M
136.22%19.64M
--8.96M
---48.31M
---4.85M
---54.22M
----
100.00%0.00
100.00%0.00
----
Net financing
-97.45%222.00K
-99.45%284.00K
-67.28%1.63M
2078.71%110.39M
31189.29%8.71M
95409.26%51.47M
229.67%4.98M
166.12%5.07M
98.36%-28.00K
-108.28%-54.00K
-97.27%1.51M
-113.69%-7.66M
-172.48%-1.70M
-95.26%652.00K
41170.15%55.30M
1933.35%55.98M
-115.07%-625.00K
2057.14%13.74M
-99.17%134.00K
23041.67%2.75M

FAQs

What are the current assets of Trevi Therapeutics Inc?

According to Trevi Therapeutics Inc's FY2025 earnings report, its current assets were 191.66M, with a year-on-year change of 75.14.

What are the total assets of Trevi Therapeutics Inc?

According to Trevi Therapeutics Inc's FY2025 earnings report, its total assets of Trevi Therapeutics Inc were 193.44M, with a year-on-year change of 74.43.

What are the total liabilities of Trevi Therapeutics Inc?

According to Trevi Therapeutics Inc's FY2025 earnings report, its total liabilities of Trevi Therapeutics Inc were 10.20M, with a year-on-year change of -9.43.

What is the total equity of Trevi Therapeutics Inc?

According to Trevi Therapeutics Inc's FY2025 earnings report, its total equity of Trevi Therapeutics Inc was 183.24M, with a year-on-year change of 83.90.

What is the net operating income of Trevi Therapeutics Inc?

According to Trevi Therapeutics Inc's FY2025 earnings report, its net operating income of Trevi Therapeutics Inc was -49.33M, with a year-on-year change of 4.26.

What is the net investment of Trevi Therapeutics Inc?

According to Trevi Therapeutics Inc's FY2025 earnings report, its net investment of Trevi Therapeutics Inc was -94.11M, with a year-on-year change of -337.14.

What is the net financing of Trevi Therapeutics Inc?

According to Trevi Therapeutics Inc's FY2025 earnings report, its net financing of Trevi Therapeutics Inc was 121.01M, with a year-on-year change of 96.82.

What is the Earnings Per Share (EPS) of Trevi Therapeutics Inc?

According to Trevi Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.32, with a year-on-year change of 32.46.

What is the net income of Trevi Therapeutics Inc?

According to Trevi Therapeutics Inc's FY2025 earnings report, its net income was -42.76M, with a year-on-year change of 10.75.

What is the Return on Equity (ROE) of Trevi Therapeutics Inc?

According to Trevi Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -30.23, with a year-on-year change of 42.52.

What is the Return on Assets (ROA) of Trevi Therapeutics Inc?

According to Trevi Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -28.10, with a year-on-year change of 41.26.

What is the operating profit of Trevi Therapeutics Inc?

According to Trevi Therapeutics Inc's FY2025 earnings report, its operating profit was -49.33M, with a year-on-year change of 4.26.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.